Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

NCT04503278

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +35 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
  • Universitätsklinikum Köln AÖR-Centrum für Integrierte Onkologie (CIO)-Studienzentrum der Klinik I für Innere Medizin (CTU Cologne) Cologne, Germany
  • Universitätsklinikum Erlangen - Hämatologie & Intrinsische Onkologie - Medizinische Klinik 5 Erlangen, Germany
View Trial Details
Active, Not Recruiting

A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

NCT05221840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site San Diego, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Stuart, Florida, United States
  • Research Site Urbana, Illinois, United States
View all 202 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06497556

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Banner Health MD Anderson AZ Gilbert, Arizona, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Hematology / Oncology Clinic Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 151 locations
View Trial Details
Active, Not Recruiting

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

NCT06443684

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of USTC / Anhui Provincial Hospital Hefei, Anhui, China
  • First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Affiliated Cancer Hospital of Harbin Medical University Harbin, Heilongjiang, China
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

NCT05941897

Conditions
Advanced or Metastatic NSCLC, Bronchial Diseases, Bronchial Neoplasms, +9 more
Locations
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
View Trial Details
Active, Not Recruiting

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

NCT04036682

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Pacific Cancer Medical Center, Inc Anaheim, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

NCT04225117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
View all 39 locations
View Trial Details

Related conditions